Dermatan sulfate-low molecular weight - Alfa Wassermann/Opocrin

Drug Profile

Dermatan sulfate-low molecular weight - Alfa Wassermann/Opocrin

Alternative Names: D 370; Desmin; Desmin 370; Low molecular weight dermatan sulfate

Latest Information Update: 28 May 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Alfa Wassermann Inc; Opocrin
  • Class Antithrombotics
  • Mechanism of Action Glycosaminoglycan stimulants; Thrombin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Deep vein thrombosis

Most Recent Events

  • 30 Jan 2001 Phase-III clinical trials for Deep vein thrombosis in Europe (IM)
  • 24 Aug 1998 A clinical study has been added to the pharmacokinetics and Thromboses pharmacodynamics sections
  • 22 Jun 1998 Investigation in Deep vein thrombosis in Europe (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top